erlotinib hydrochloride has been researched along with ethylene oxide in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (ethylene oxide) | Trials (ethylene oxide) | Recent Studies (post-2010) (ethylene oxide) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 2,967 | 20 | 432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asgari, D; Barar, J; Barghi, L; Nakhlband, A; Valizadeh, H | 1 |
1 other study(ies) available for erlotinib hydrochloride and ethylene oxide
| Article | Year |
|---|---|
Synthesis, characterization and in vitro anti-tumoral evaluation of Erlotinib-PCEC nanoparticles.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Ethylene Oxide; Humans; In Vitro Techniques; Lactones; Nanoparticles; Protein Kinase Inhibitors; Proton Magnetic Resonance Spectroscopy; Quinazolines; Spectroscopy, Fourier Transform Infrared | 2014 |